The FXR agonist obeticholic acid inhibits the cancerogenic potential of human ch
- This topic has 0 replies, 1 voice, and was last updated 5 years, 5 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma.
https://www.ncbi.nlm.nih.gov/pubmed/30677052
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.